TWD 70.8
(0.28%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -1.56 TWD | 29.09% |
2022 | -2.20 TWD | 3.08% |
2021 | -2.27 TWD | 25.57% |
2020 | -3.05 TWD | 8.41% |
2019 | -3.33 TWD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.45 TWD | 21.05% |
2024 Q1 | -0.57 TWD | -23.91% |
2023 Q3 | -0.46 TWD | -53.33% |
2023 FY | - TWD | 29.09% |
2023 Q2 | -0.30 TWD | 16.67% |
2023 Q1 | -0.36 TWD | 40.98% |
2023 Q4 | -0.46 TWD | 0.0% |
2022 FY | - TWD | 3.08% |
2022 Q4 | -0.61 TWD | 0.0% |
2021 FY | - TWD | 25.57% |
2020 FY | - TWD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Apex Biotechnology Corp. | 1.16 TWD | 234.483% |
Sinphar Pharmaceutical Co.,Ltd. | 2.24 TWD | 169.643% |
Panion & Bf Biotech Inc. | 0.90 TWD | 273.333% |
Chunghwa Chemical Synthesis & Biotech Co., Ltd. | 3.42 TWD | 145.614% |
GenMont Biotech Incorporation | 0.38 TWD | 510.526% |
Abnova (Taiwan) Corporation | 0.72 TWD | 316.667% |
Adimmune Corporation | -1.52 TWD | -2.632% |
Tanvex BioPharma, Inc. | -16.42 TWD | 90.499% |
Polaris Group | -2.12 TWD | 26.415% |
Energenesis Biomedical CO.,LTD. | -3.62 TWD | 56.906% |
PELL Bio-Med Technology Co. Ltd. | -8.62 TWD | 81.903% |